Business
Press Release Oct 31 2025
Strides Pharma Science Limited has informed the Exchange regarding a press release dated October 31, 2025, titled "Strides Delivers a Robust Q2FY26 with Highest Ever Quarterly EPSQ2FY26 Operational PAT at ₹1,403m and EPS at ₹15.2, Grew 84% YoY".
About this update from Strides Pharma Science Ltd
Strides Pharma Science Limited has informed the Exchange regarding a press release dated October 31, 2025, titled "Strides Delivers a Robust Q2FY26 with Highest Ever Quarterly EPSQ2FY26 Operational PAT at ₹1,403m and EPS at ₹15.2, Grew 84% YoY". View Attachment
View stock analysis, news, and events for Strides Pharma Science Ltd